| Literature DB >> 33129263 |
Katrin C Reber1, Ivonne Lindlbauer1, Claudia Schulz1, Kilian Rapp2, Hans-Helmut König3.
Abstract
BACKGROUND: A growing number of older people are care dependent and live in nursing homes, which accounts for the majority of long-term-care spending. Specific medical conditions and resident characteristics may serve as risk factors predicting negative health outcomes. We investigated the association between the risk of increasing care need and chronic medical conditions among nursing home residents, allowing for the competing risk of mortality.Entities:
Keywords: Care need; Competing risk; Long-term care; Mortality; Nursing home
Year: 2020 PMID: 33129263 PMCID: PMC7603768 DOI: 10.1186/s12877-020-01847-7
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Resident characteristics according to care level at admission
| Care level 1 | Care level 2 | |||
|---|---|---|---|---|
| N (%) | N (%) | |||
| Age (in yrs) at nursing home admission, mean (SD) | 83.8 | (6.3) | 84.1 | (6.5) |
| Age group (at baseline) | ||||
| 65- < 75 yrs | 967 | (9.6) | 994 | (9.5) |
| 75- < 84 yrs | 4444 | (44.2) | 4514 | (43.2) |
| 85- < 94 yrs | 4371 | (43.5) | 4483 | (43) |
| 95+ yrs | 266 | (2.6) | 446 | (4.3) |
| Female | 6360 | (63.3) | 6245 | (59.8) |
| Follow-up | ||||
| Care level change | 4962 | (49.4) | 2613 | (25) |
| Mortality | 2523 | (25.1) | 5337 | (51.1) |
| Hospitalization stay (before baseline) | ||||
| Up to 60 days | 5633 | (56.1) | 6034 | (57.8) |
| Medical conditions (at baseline) | ||||
| Alcohol abuse | 261 | (2.6) | 221 | (2.1) |
| Any tumor | 1649 | (16.4) | 1837 | (17.6) |
| Blood loss anemia | 113 | (1.1) | 117 | (1.1) |
| Cardiac arrhythmias | 3736 | (37.2) | 4026 | (38.6) |
| Cerebrovascular disease | 3226 | (32.1) | 4313 | (41.3) |
| Chronic pulmonary disease | 2454 | (24.4) | 2497 | (23.9) |
| Coagulopathy | 498 | (5.0) | 477 | (4.6) |
| Complicated diabetes | 1398 | (13.9) | 1506 | (14.4) |
| Congestive heart failure | 4848 | (48.2) | 5212 | (49.9) |
| Deficiency anemias | 822 | (8.2) | 846 | (8.1) |
| Dementia | 4235 | (42.1) | 5303 | (50.8) |
| Depression | 3209 | (31.9) | 3076 | (29.5) |
| Drug abuse | 103 | (1.0) | 89 | (0.9) |
| Fluid and electrolyte disorders | 1730 | (17.2) | 2284 | (21.9) |
| Hypertension | 7834 | (78.0) | 7996 | (76.6) |
| Hypothyroidism | 829 | (8.3) | 864 | (8.3) |
| Liver disease | 934 | (9.3) | 822 | (7.9) |
| Metastatic cancer | 397 | (4.0) | 576 | (5.5) |
| Myocardial infarction | 581 | (5.8) | 615 | (5.9) |
| Neurodegenerative disorders | 1456 | (14.5) | 2305 | (22.1) |
| Obesity | 1127 | (11.2) | 1153 | (11.0) |
| Paralysis | 573 | (5.7) | 1379 | (13.2) |
| Peripheral vascular disorder | 1991 | (19.8) | 2092 | (20.0) |
| Psychosis | 554 | (5.5) | 555 | (5.3) |
| Pulmonary circulation disorders | 445 | (4.4) | 443 | (4.2) |
| Renal failure | 2181 | (21.7) | 2350 | (22.5) |
| Rheumatoid arthritis/collagen vascular diseases | 773 | (7.7) | 792 | (7.6) |
| Ulcer disease | 344 | (3.4) | 392 | (3.8) |
| Uncomplicated diabetes | 3096 | (30.8) | 3373 | (32.3) |
| Valvular disease | 1464 | (14.6) | 1448 | (13.9) |
| Weight loss | 456 | (4.5) | 570 | (5.5) |
Unless otherwise indicated, values are expressed as numbers (percentages) of individuals
yrs years, SD standard deviation
Fig. 1Cumulative incidence curves of care level change and mortality for residents admitted with care level 1 (a) and care level 2 (b)
Results of the multivariate subdistribution hazard models for care level change and the competing event mortality, stratified by care level at admission
| Care level 1 at admission | Care level 2 at admission | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Care level change | Mortality | Care level change | Mortality | |||||||||
| sHR | 95% CI | sHR | 95% CI | sHR | 95% CI | sHR | 95% CI | |||||
| Female | 1.03 | 0.97–1.10 | 0.76 | 0.69–0.82 | < 0.001 | 1.04 | 0.96–1.13 | 0.85 | 0.80–0.90 | < 0.001 | ||
| Age (per 10-y increase) | 1.02 | 0.98–1.07 | 1.41 | 1.31–1.52 | < 0.001 | 0.85 | 0.80–0.90 | < 0.001 | 1.26 | 1.20–1.32 | < 0.001 | |
| Hospitalization stay (60 days before) | 0.84 | 0.79–0.88 | < 0.001 | 1.48 | 1.36–1.61 | < 0.001 | 0.77 | 0.71–0.83 | < 0.001 | 1.43 | 1.35–1.52 | < 0.001 |
| Myocardial infarction | 0.81 | 0.70–0.92 | < 0.01 | 1.33 | 1.14–1.55 | < 0.001 | 0.79 | 0.65–0.96 | < 0.02 | 1.29 | 1.15–1.44 | < 0.001 |
| Congestive heart failure | 0.93 | 0.87–0.98 | < 0.01 | 1.22 | 1.12–1.33 | < 0.001 | 0.83 | 0.77–0.90 | < 0.001 | 1.17 | 1.11–1.25 | < 0.001 |
| Peripheral vascular disorder | 0.97 | 0.90–1.05 | 1.08 | 0.98–1.19 | 1.01 | 0.91–1.12 | 1.04 | 0.97–1.11 | ||||
| Cardiac arrhythmias | 0.97 | 0.91–1.03 | 1.13 | 1.04–1.23 | < 0.01 | 0.90 | 0.82–0.98 | < 0.02 | 1.14 | 1.08–1.21 | < 0.001 | |
| Valvular disease | 0.95 | 0.87–1.04 | 1.11 | 1.00–1.25 | 0.94 | 0.83–1.07 | 1.05 | 0.97–1.14 | ||||
| Coagulopathy | 0.86 | 0.74–0.99 | < 0.04 | 1.12 | 0.95–1.33 | 0.87 | 0.70–1.09 | 1.07 | 0.94–1.22 | |||
| Chronic pulmonary disease | 0.95 | 0.89–1.02 | 1.14 | 1.04–1.25 | < 0.01 | 0.93 | 0.84–1.02 | 1.11 | 1.04–1.18 | < 0.01 | ||
| Pulmonary circulation disorders | 0.90 | 0.78–1.05 | 1.17 | 0.98–1.40 | 0.85 | 0.68–1.07 | 1.15 | 1.01–1.31 | < 0.05 | |||
| Rheumatoid arthritis/collagen vascular d. | 0.95 | 0.85–1.05 | 0.99 | 0.85–1.15 | 0.91 | 0.79–1.06 | 1.06 | 0.96–1.18 | ||||
| Ulcer disease | 0.83 | 0.71–0.98 | < 0.03 | 1.24 | 1.01–1.53 | < 0.05 | 0.91 | 0.72–1.13 | 1.04 | 0.91–1.19 | ||
| Any tumor | 0.91 | 0.83–0.99 | < 0.04 | 1.44 | 1.30–1.60 | < 0.001 | 0.72 | 0.63–0.82 | < 0.001 | 1.50 | 1.39–1.62 | < 0.001 |
| Metastatic cancer | 0.67 | 0.54–0.83 | < 0.001 | 2.45 | 2.06–2.92 | < 0.001 | 0.44 | 0.32–0.59 | < 0.001 | 2.27 | 1.99–2.58 | < 0.001 |
| Cerebrovascular disease | 1.06 | 1.00–1.12 | 0.94 | 0.86–1.03 | 0.98 | 0.91–1.06 | 1.01 | 0.95–1.07 | ||||
| Dementia | 1.43 | 1.36–1.51 | < 0.001 | 0.73 | 0.67–0.80 | < 0.001 | 1.74 | 1.60–1.89 | < 0.001 | 0.73 | 0.69–0.78 | < 0.001 |
| Neurodegenerative disorders | 1.10 | 1.02–1.18 | < 0.02 | 0.92 | 0.82–1.04 | 0.17 | 1.03 | 0.94–1.13 | 0.48 | 0.99 | 0.93–1.06 | 0.80 |
| Paralysis | 1.04 | 0.92–1.17 | 1.01 | 0.84–1.22 | 1.00 | 0.89–1.13 | 0.88 | 0.80–0.96 | < 0.01 | |||
| Complicated diabetes | 1.05 | 0.96–1.15 | 0.95 | 0.83–1.08 | 0.90 | 0.79–1.02 | 1.10 | 1.00–1.20 | < 0.05 | |||
| Uncomplicated diabetes | 1.04 | 0.97–1.11 | 1.04 | 0.94–1.14 | 1.00 | 0.91–1.09 | 1.00 | 0.93–1.06 | ||||
| Renal failure | 0.97 | 0.90–1.05 | 1.19 | 1.08–1.31 | < 0.001 | 0.88 | 0.79–0.97 | < 0.02 | 1.16 | 1.08–1.24 | < 0.001 | |
| Liver disease | 1.06 | 0.96–1.17 | 0.99 | 0.86–1.14 | 0.90 | 0.77–1.05 | 1.05 | 0.94–1.16 | ||||
| Obesity | 1.00 | 0.92–1.09 | 0.95 | 0.83–1.09 | 1.02 | 0.90–1.16 | 0.87 | 0.80–0.96 | < 0.01 | |||
| Depression | 0.96 | 0.91–1.02 | 0.95 | 0.87–1.04 | 0.98 | 0.90–1.06 | 0.94 | 0.89–1.00 | ||||
| Hypertension | 0.98 | 0.91–1.04 | 0.96 | 0.87–1.06 | 1.06 | 0.97–1.16 | 0.93 | 0.87–0.99 | < 0.04 | |||
| Hypothyroidism | 0.96 | 0.87–1.06 | 0.98 | 0.84–1.13 | 1.07 | 0.94–1.23 | 0.91 | 0.82–1.01 | ||||
| Fluid and electrolyte disorders | 1.08 | 1.00–1.17 | < 0.04 | 1.03 | 0.93–1.15 | 1.00 | 0.91–1.10 | 1.04 | 0.97–1.11 | |||
| Blood loss anemia | 1.01 | 0.74–1.39 | 0.95 | 0.65–1.39 | 0.85 | 0.58–1.23 | 1.20 | 0.96–1.50 | ||||
| Deficiency anemias | 0.93 | 0.83–1.03 | 1.09 | 0.95–1.25 | 0.92 | 0.79–1.07 | 1.08 | 0.97–1.19 | ||||
| Weight loss | 0.87 | 0.76–1.01 | 1.51 | 1.27–1.78 | < 0.001 | 0.85 | 0.70–1.04 | 1.38 | 1.23–1.55 | < 0.001 | ||
| Alcohol abuse | 0.82 | 0.69–0.98 | < 0.03 | 1.28 | 0.99–1.65 | 0.78 | 0.58–1.03 | 1.07 | 0.88–1.30 | |||
| Drug abuse | 0.98 | 0.75–1.29 | 0.65 | 0.39–1.08 | 1.06 | 0.71–1.58 | 1.01 | 0.76–1.35 | ||||
| Psychosis | 0.93 | 0.84–1.05 | 1.00 | 0.83–1.21 | 0.95 | 0.81–1.11 | 0.88 | 0.78–1.00 | ||||
sHR subdistribution hazard ratio, CI confidence interval, y year; collagen vascular d., collagen vascular disease